Cspc-nbp Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CSPC-NBP PHARM, and what generic and branded alternatives to CSPC-NBP PHARM drugs are available?
CSPC-NBP PHARM has two approved drugs.
Summary for Cspc-nbp Pharm
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Cspc-nbp Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cspc-nbp Pharm | BENZONATATE | benzonatate | CAPSULE;ORAL | 202765-002 | Aug 25, 2017 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Cspc-nbp Pharm | BENZONATATE | benzonatate | CAPSULE;ORAL | 202765-001 | Jul 31, 2015 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Cspc-nbp Pharm | OMEGA-3-ACID ETHYL ESTERS | omega-3-acid ethyl esters | CAPSULE;ORAL | 211979-001 | May 12, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
